Spire Wealth Management
FMED icon

Spire Wealth Management’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Spire Wealth Management’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$73.1K Buy
+2,258
New +$68.9K ﹤0.01% 1027

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Rydar Equities
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Central Pacific Bank - Trust Division
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
Glass Jacobson Investment Advisors
Glass Jacobson Investment Advisors Owings Mills, Maryland $326M AUM 13.52% 1-Year Est. Return

Spire Wealth Management's FMED Position: Q3 2026 in Review

Spire Wealth Management opened a new position in Fidelity Disruptive Medicine ETF (FMED) in Q3 2026: 2,258 shares worth $73.1K. The stake represents ﹤0.01% of the portfolio and ranks #1027 among its holdings.

8 funds tracked by Wall St. Rank hold FMED as of Q3 2026.

  • Spire Wealth Management held 2,258 shares of Fidelity Disruptive Medicine ETF worth $73.1K as of Q3 2026.
  • Fidelity Disruptive Medicine ETF was a new Spire Wealth Management position in Q3 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #1027 holding.
  • 8 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.